137 related articles for article (PubMed ID: 7843268)
1. Estimates of antagonist affinities at P2X purinoceptors in rat vas deferens.
Khakh BS; Michel A; Humphrey PP
Eur J Pharmacol; 1994 Oct; 263(3):301-9. PubMed ID: 7843268
[TBL] [Abstract][Full Text] [Related]
2. Concomitant blockade of P2X-receptors and ecto-nucleotidases by P2-receptor antagonists: functional consequences in rat vas deferens.
Bültmann R; Trendelenburg M; Tuluc F; Wittenburg H; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):339-44. PubMed ID: 10344533
[TBL] [Abstract][Full Text] [Related]
3. High affinity P2x-purinoceptor binding sites for [35S]-adenosine 5'-O-[3-thiotriphosphate] in rat vas deferens membranes.
Michel AD; Humphrey PP
Br J Pharmacol; 1996 Jan; 117(1):63-70. PubMed ID: 8825344
[TBL] [Abstract][Full Text] [Related]
4. The use of antagonists to characterize the receptors mediating depolarization of the rat isolated vagus nerve by alpha, beta-methylene adenosine 5'-triphosphate.
Trezise DJ; Kennedy I; Humphrey PP
Br J Pharmacol; 1994 May; 112(1):282-8. PubMed ID: 8032652
[TBL] [Abstract][Full Text] [Related]
5. P2 purinoceptor antagonist properties of pyridoxal-5-phosphate.
Trezise DJ; Bell NJ; Khakh BS; Michel AD; Humphrey PA
Eur J Pharmacol; 1994 Jul; 259(3):295-300. PubMed ID: 7982456
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of P2-purinoceptor antagonists at two relaxation-mediating P2-purinoceptors in guinea-pig taenia coli.
Bültmann R; Dudeck O; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar; 353(4):445-51. PubMed ID: 8935712
[TBL] [Abstract][Full Text] [Related]
7. Distribution and characterisation of [3H]alpha,beta-methylene ATP binding sites in the rat.
Michel AD; Humphrey PP
Naunyn Schmiedebergs Arch Pharmacol; 1993 Dec; 348(6):608-17. PubMed ID: 8133903
[TBL] [Abstract][Full Text] [Related]
8. PPADS selectively antagonizes P2X-purinoceptor-mediated responses in the rabbit urinary bladder.
Ziganshin AU; Hoyle CH; Bo X; Lambrecht G; Mutschler E; Bäumert HG; Burnstock G
Br J Pharmacol; 1993 Dec; 110(4):1491-5. PubMed ID: 8306091
[TBL] [Abstract][Full Text] [Related]
9. The binding characteristics of a human bladder recombinant P2X purinoceptor, labelled with [3H]-alpha beta meATP, [35S]-ATP gamma S or [33P]-ATP.
Michel AD; Lundström K; Buell GN; Surprenant A; Valera S; Humphrey PP
Br J Pharmacol; 1996 Mar; 117(6):1254-60. PubMed ID: 8882623
[TBL] [Abstract][Full Text] [Related]
10. P2-purinoceptor antagonists discriminate three contraction-mediating receptors for ATP in rat vas deferens.
Bültmann R; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1994 Jan; 349(1):74-80. PubMed ID: 8139703
[TBL] [Abstract][Full Text] [Related]
11. Design and pharmacology of selective P2-purinoceptor antagonists.
Lambrecht G
J Auton Pharmacol; 1996 Dec; 16(6):341-4. PubMed ID: 9131412
[TBL] [Abstract][Full Text] [Related]
12. Blockade of P2X-purinoceptors by trypan blue in rat vas deferens.
Bültmann R; Trendelenburg M; Starke K
Br J Pharmacol; 1994 Oct; 113(2):349-54. PubMed ID: 7834182
[TBL] [Abstract][Full Text] [Related]
13. Nucleotide-evoked relaxation of rat vas deferens--a possible role for endogenous ATP released upon alpha(1)-adrenoceptor stimulation.
Bültmann R; Starke K
Eur J Pharmacol; 2001 Jun; 422(1-3):197-202. PubMed ID: 11430931
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the binding characteristics of recombinant P2X1 and P2X2 purinoceptors.
Michel AD; Lundström K; Buell GN; Surprenant A; Valera S; Humphrey PP
Br J Pharmacol; 1996 Aug; 118(7):1806-12. PubMed ID: 8842447
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the actions of PPADS, a novel P2x-purinoceptor antagonist, in the guinea-pig isolated vas deferens.
McLaren GJ; Lambrecht G; Mutschler E; Bäumert HG; Sneddon P; Kennedy C
Br J Pharmacol; 1994 Mar; 111(3):913-7. PubMed ID: 8019769
[TBL] [Abstract][Full Text] [Related]
16. The interaction of diadenosine polyphosphates with P2x-receptors in the guinea-pig isolated vas deferens.
Westfall TD; McIntyre CA; Obeid S; Bowes J; Kennedy C; Sneddon P
Br J Pharmacol; 1997 May; 121(1):57-62. PubMed ID: 9146887
[TBL] [Abstract][Full Text] [Related]
17. P2X purinoceptors in the feline pulmonary vascular bed: distribution and selective in vivo pharmacological probes.
Neely CF; Matot I; Batra VK; Bo X; Burnstock G
Am J Physiol; 1996 Jun; 270(6 Pt 1):L889-97. PubMed ID: 8764212
[TBL] [Abstract][Full Text] [Related]
18. Identification of atropine- and P2X1 receptor antagonist-resistant, neurogenic contractions of the urinary bladder.
Kennedy C; Tasker PN; Gallacher G; Westfall TD
J Neurosci; 2007 Jan; 27(4):845-51. PubMed ID: 17251425
[TBL] [Abstract][Full Text] [Related]
19. Calcium handling and purinoceptor subtypes involved in ATP-induced contraction in rat small mesenteric arteries.
Lagaud GJ; Stoclet JC; Andriantsitohaina R
J Physiol; 1996 May; 492 ( Pt 3)(Pt 3):689-703. PubMed ID: 8734982
[TBL] [Abstract][Full Text] [Related]
20. A study on P2X purinoceptors mediating the electrophysiological and contractile effects of purine nucleotides in rat vas deferens.
Khakh BS; Surprenant A; Humphrey PP
Br J Pharmacol; 1995 May; 115(1):177-85. PubMed ID: 7647973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
